1. Home
  2. POAI vs WAFU Comparison

POAI vs WAFU Comparison

Compare POAI & WAFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POAI
  • WAFU
  • Stock Information
  • Founded
  • POAI 2002
  • WAFU 1999
  • Country
  • POAI United States
  • WAFU China
  • Employees
  • POAI N/A
  • WAFU N/A
  • Industry
  • POAI Industrial Specialties
  • WAFU Other Consumer Services
  • Sector
  • POAI Health Care
  • WAFU Real Estate
  • Exchange
  • POAI Nasdaq
  • WAFU Nasdaq
  • Market Cap
  • POAI 8.9M
  • WAFU N/A
  • IPO Year
  • POAI N/A
  • WAFU 2019
  • Fundamental
  • Price
  • POAI $1.07
  • WAFU $1.48
  • Analyst Decision
  • POAI Hold
  • WAFU
  • Analyst Count
  • POAI 1
  • WAFU 0
  • Target Price
  • POAI N/A
  • WAFU N/A
  • AVG Volume (30 Days)
  • POAI 104.2K
  • WAFU 40.8K
  • Earning Date
  • POAI 05-20-2025
  • WAFU 01-01-0001
  • Dividend Yield
  • POAI N/A
  • WAFU N/A
  • EPS Growth
  • POAI N/A
  • WAFU N/A
  • EPS
  • POAI N/A
  • WAFU N/A
  • Revenue
  • POAI $1,623,817.00
  • WAFU $6,374,594.00
  • Revenue This Year
  • POAI $486.27
  • WAFU N/A
  • Revenue Next Year
  • POAI $65.50
  • WAFU N/A
  • P/E Ratio
  • POAI N/A
  • WAFU N/A
  • Revenue Growth
  • POAI N/A
  • WAFU N/A
  • 52 Week Low
  • POAI $0.55
  • WAFU $1.22
  • 52 Week High
  • POAI $3.06
  • WAFU $7.49
  • Technical
  • Relative Strength Index (RSI)
  • POAI 48.41
  • WAFU 51.88
  • Support Level
  • POAI $0.85
  • WAFU $1.36
  • Resistance Level
  • POAI $1.23
  • WAFU $1.49
  • Average True Range (ATR)
  • POAI 0.09
  • WAFU 0.09
  • MACD
  • POAI 0.01
  • WAFU 0.02
  • Stochastic Oscillator
  • POAI 57.29
  • WAFU 78.43

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: